Ivygene Diagnostics
IvyGene Biotechnology, through its Laboratory for Advanced Medicine (LAM), offers a revolutionary cancer detection blood test that utilizes AI and next-generation sequencing to analyze DNA methylation patterns of circulating tumor DNA (ctDNA). The IvyGene Platform identifies specific gene targets with higher methylation levels when cancer is present, providing a simple blood draw to confirm multiple cancers early, as accurately as stage 1. Unlike genetic tests that predict cancer risk, IvyGene identifies actual disease presence through DNA methylation patterns. LAM is a CLIA and CAP certified laboratory with cGMP facilities, operating globally with collaborations in the US and China. The company aims to shift cancer detection from a reactive to a proactive approach, making testing accessible and affordable.
Ivygene Diagnostics
IvyGene Biotechnology, through its Laboratory for Advanced Medicine (LAM), offers a revolutionary cancer detection blood test that utilizes AI and next-generation sequencing to analyze DNA methylation patterns of circulating tumor DNA (ctDNA). The IvyGene Platform identifies specific gene targets with higher methylation levels when cancer is present, providing a simple blood draw to confirm multiple cancers early, as accurately as stage 1. Unlike genetic tests that predict cancer risk, IvyGene identifies actual disease presence through DNA methylation patterns. LAM is a CLIA and CAP certified laboratory with cGMP facilities, operating globally with collaborations in the US and China. The company aims to shift cancer detection from a reactive to a proactive approach, making testing accessible and affordable.